| |
| |
|
| Insider
Information: |
Wolff Andrew A |
| Relationship: |
SVP & CMO |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
53,779 |
|
|
Indirect Shares
|
1,523 |
|
|
| Direct
Value |
$2,934,536 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,302 |
|
|
| Total
Value |
$2,934,536 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
CV Therapeutics Inc |
CVTX |
Senior Vice President |
2004-01-13 |
6,524 |
2004-01-13 |
1,523 |
Premium* |
|
|
Cytokinetics Inc |
CYTK |
SVP & CMO |
2017-02-28 |
47,255 |
2012-09-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
SVP & CMO |
• – – |
2017-02-28 |
4 |
D |
$10.60 |
$52,830 |
D/D |
(4,984) |
32,255 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP & CMO |
• – – |
2017-02-28 |
4 |
A |
$0.00 |
$28 |
D/D |
27,500 |
47,255 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP & CMO |
• – – |
2015-03-11 |
4 |
OE |
$6.30 |
$137,813 |
D/D |
21,875 |
43,036 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP & CMO |
• – – |
2015-03-11 |
4 |
S |
$7.80 |
$170,638 |
D/D |
(21,875) |
21,261 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP Clinical R&D, CMO |
• – – |
2013-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,583 |
26,116 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP Clinical R&D, CMO |
• – – |
2013-09-03 |
4 |
D |
$7.65 |
$41,914 |
D/D |
(5,479) |
20,637 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP Clinical R&D, CMO |
• – – |
2012-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
87,500 |
98,750 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP Clinical R&D, CMO |
• – – |
2012-09-04 |
4 |
D |
$0.76 |
$24,353 |
D/D |
(32,052) |
66,698 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Senior Vice President |
• – – |
2004-01-13 |
4 |
A |
$14.67 |
$10,000 |
I/I |
682 |
1,524 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
